Search
Hematology and oncology, pacemakers for EU HTA
EHA’s Martin Kaiser, right, addressing his fellow panelists. Left to right: Brian Cuffel (Bayer), Caroline Pothet (EMA), Roisin Adams (HTA CG), Bernhard Wörmann (DGHO) and Elisabeth de Vries (ESMO).
Read morePatient organizations
EHA greatly values the collaboration with patient organizations in a growing number of areas, from joint advocacy and a strong presence at the EHA Annual Congress – with a prominent place for the EHA-Patient Joint Symposium on policy and regulatory…
Read moreEHA-HKSH Hematology Tutorial
EHA is joining the Hong Kong Society of Hematology (HKSH) to organize the EHA-HKSH Hematology Tutorial on Lymphoid Malignancies.
Read morePosition of EHA on Clinical Trials
The challenge
In Europe, the number of clinical trials is steadily decreasing. From 2007 to 2010, their number has decreased by some 20 percent from 5,028 to 4,193.
Challenging the safety of conformity: Better poster design to disseminate scientific knowledge fast
“Congratulations – your abstract was accepted for the upcoming EHA congress”.
Read moreEHA-SAH Hematology Tutorial on Lymphoid Malignancies and Plasma Cell Dyscrasias
Dates: September 14-15, 2018
Location: Buenos Aires, Argentina
Chairs: D Fantl, R Foà
Co-chair: G Kusminsky
Following successful previous editions, EHA is organizing the second two-day tutorial in close collaboration with the Sociedad Argentina de Hematología (SAH) on “Lymphoid Malignancies and Plasma Cell Dyscrasias”.…